Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|May 3, 2019

Eppendorf Hosts Vaccine Development and Bioprocess Cell Culture Technology Day

The Vaccine Development and Bioprocess Cell Culture Technology Day will take place on May 16, 2019 in Baltimore, MD.

Laboratory instrument and service provider Eppendorf announced that it will host the Vaccine Development and Bioprocess Cell Culture Technology Day on May 16, 2019 at the BWI Airport Marriott in Baltimore, MD. During the event, experts will discuss technologies in cell culture upstream bioprocess development with a special focus on perfusion technologies and scale-up. 

“Today, scalable bioprocess systems, online process analytics, and process intensification are key for the development of robust, cost-efficient bioprocesses,” said Dr. Karl Rix, vice-president, business unit bioprocess, Eppendorf, in a company press release. “We are excited that bioprocess experts from Eppendorf, as well as representatives from Corning and other leading manufacturers, will share their latest bioprocess insights.”

For registration and further information, visit the event website or contact cellexperts@eppendorf.com.

Source: Eppendorf


Related to this article

The BioPharm Brief: FDA’s Fast-Track Pilot Reportedly Stalls, a Long-Acting Bispecific for Atopic Dermatitis, and a Twice-Yearly Obesity Approach
FDA has reportedly shelved its Commissioner’s National Priority Voucher pilot and paused publishing complete response letters, Zai Lab’s IL-13/IL-31Rα bispecific ZL-1503 shows a 40- to 50-day half-life that points to dosing every 12 weeks, and Wave Life Sciences reports 1-year INLIGHT data for its INHBE-silencing siRNA WVE-007 in obesity.